Biogen takes another blow as appeal for Tecfidera patent revival falls short fkansteiner Tue, 11/30/2021 – 15:13 More: Biogen takes another blow as appeal for Tecfidera patent revival falls short Source: fierce
read moreAfter flunking key trial, Deciphera cuts 140 jobs, halts development of two drugs kdunleavy Tue, 11/30/2021 – 14:14 More: After flunking key trial, Deciphera cuts 140 jobs, halts development of two drugs Source: fierce
read moreGSK’s ViiV looks to future of injectable HIV treatment as long-acting PrEP decision looms fkansteiner Tue, 11/30/2021 – 11:10 More: GSK's ViiV looks to future of injectable HIV treatment as long-acting PrEP decision looms Source: fierce
read moreBristol Myers Squibb’s next-gen autoimmune med starts high-stakes FDA review amid classwide JAK scrutiny aliu Tue, 11/30/2021 – 10:30 More: Bristol Myers Squibb's next-gen autoimmune med starts high-stakes FDA review amid classwide JAK scrutiny Source: fierce
read moreModerna, Regeneron warn about the effectiveness of COVID-19 drugs, vaccines against the omicron variant kdunleavy Tue, 11/30/2021 – 09:57 More: Moderna, Regeneron warn about the effectiveness of COVID-19 drugs, vaccines against the omicron variant Source: fierce
read moreThe Scottish government aims to expand and advance their COVID-19 booster programme, following the six cases of the Omicron variant that were reported as of Monday 29 November. This decision is based on advice from the Joint Committee on Vaccination
read more© 1994 - 2023 B.M. Pharmaceuticals